{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:37:29Z","timestamp":1759937849151},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,27]]},"DOI":"10.7759\/cureus.67960","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T21:45:35Z","timestamp":1724795135000},"source":"Crossref","is-referenced-by-count":1,"title":["Pre-transplant Loco-Regional Therapy for Hepatocellular Carcinoma and Post-transplant Outcomes: A National Study"],"prefix":"10.7759","author":[{"given":"Jay","family":"Desai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond I","family":"Okeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshani","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabel","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Schnitzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Barron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chintalapati R","family":"Varma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry B","family":"Randall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista L","family":"Lentine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Nazzal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro V","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R, et al.. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996, 334:693-9. 10.1056\/NEJM199603143341104","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath PS","year":"2001","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, et al.. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001, 33:464-70. 10.1053\/jhep.2001.22172","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner R","year":"2003","unstructured":"Wiesner R, Edwards E, Freeman R, et al.. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003, 124:91-6. 10.1053\/gast.2003.50016","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v12.i1.32","article-title":"Liver transplant allocation policies and outcomes in United States: a comprehensive review","volume":"12","author":"Latt NL","year":"2022","unstructured":"Latt NL, Niazi M, Pyrsopoulos NT. Liver transplant allocation policies and outcomes in United States: a comprehensive review. World J Methodol. 2022, 12:32-42. 10.5662\/wjm.v12.i1.32","journal-title":"World J Methodol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.1.123","article-title":"Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation","volume":"50","author":"Llovet JM","year":"2002","unstructured":"Llovet JM, Mas X, Aponte JJ, et al.. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut. 2002, 50:123-8. 10.1136\/gut.50.1.123","journal-title":"Gut"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-0071-3","article-title":"Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation","volume":"15","author":"Heckman JT","year":"2008","unstructured":"Heckman JT, Devera MB, Marsh JW, et al.. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann Surg Oncol. 2008, 15:3169-77. 10.1245\/s10434-008-0071-3","journal-title":"Ann Surg Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-007-9111-9","article-title":"Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate","volume":"30","author":"Stockland AH","year":"2007","unstructured":"Stockland AH, Walser EM, Paz-Fumagalli R, McKinney JM, May GR. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate. Cardiovasc Intervent Radiol. 2007, 30:888-93. 10.1007\/s00270-007-9111-9","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.15761\/GOS.1000171","article-title":"Liver targeted therapies for hepatocellular carcinoma prior to transplant: contemporary management strategies","volume":"4","author":"Nazzal M","year":"2018","unstructured":"Nazzal M, Gadani S, Said A, Rice M, Okoye O, Taha A, Lentine KL. Liver targeted therapies for hepatocellular carcinoma prior to transplant: contemporary management strategies. Glob Surg. 2018, 4:10.15761\/GOS.1000171","journal-title":"Glob Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000367739","article-title":"Surgical and Locoregional Therapy of HCC: TACE","volume":"4","author":"Tsurusaki M","year":"2015","unstructured":"Tsurusaki M, Murakami T. Surgical and Locoregional Therapy of HCC: TACE. Liver Cancer. 2015, 4:165-75. 10.1159\/000367739","journal-title":"Liver Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics5040546","article-title":"The Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging Biomarkers","volume":"5","author":"Ludwig JM","year":"2015","unstructured":"Ludwig JM, Camacho JC, Kokabi N, Xing M, Kim HS. The Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging Biomarkers. Diagnostics (Basel). 2015, 5:546-63. 10.3390\/diagnostics5040546","journal-title":"Diagnostics (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002381","article-title":"Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium","volume":"266","author":"Agopian VG","year":"2017","unstructured":"Agopian VG, Harlander-Locke MP, Ruiz RM, et al.. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium. Ann Surg. 2017, 266:525-35. 10.1097\/SLA.0000000000002381","journal-title":"Ann Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20418","article-title":"Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma","volume":"11","author":"Decaens T","year":"2005","unstructured":"Decaens T, Roudot-Thoraval F, Bresson-Hadni S, et al.. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl. 2005, 11:767-75. 10.1002\/lt.20418","journal-title":"Liver Transpl"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22365","article-title":"Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience","volume":"17 Suppl 2","author":"Mazzaferro V","year":"2011","unstructured":"Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, Miceli R, Mariani L. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl. 2011, 17 Suppl 2:S44-57. 10.1002\/lt.22365","journal-title":"Liver Transpl"},{"key":"ref14","unstructured":"Organ Procurement and Transplantation Network. Organ procurement and transplantation network (OPTN) policies. Effective date October 27, 2022. Accessed October 28, 2022. https.\/\/optn.transplant.hrsa.gov\/media\/eavh5bf3\/optn_policies.pdf."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"Yao FY","year":"2001","unstructured":"Yao FY, Ferrell L, Bass NM, et al.. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001, 33:1394-403. 10.1053\/jhep.2001.24563","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.02.018","article-title":"UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies","volume":"21","author":"Tan DJ","year":"2023","unstructured":"Tan DJ, Lim WH, Yong JN, et al.. UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies. Clin Gastroenterol Hepatol. 2023, 21:1475-84. 10.1016\/j.cgh.2022.02.018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31210","article-title":"Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria","volume":"72","author":"Kardashian A","year":"2020","unstructured":"Kardashian A, Florman SS, Haydel B, et al.. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. Hepatology. 2020, 72:2014-28. 10.1002\/hep.31210","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.21037\/tgh.2020.01.06","article-title":"Comparison between Milan and UCSF criteria for liver transplantation in patients with hepatocellular carcinoma: a systematic review and meta-analysis","volume":"6","author":"Bento de Sousa JH","year":"2021","unstructured":"Bento de Sousa JH, Calil IL, Tustumi F, da Cunha Khalil D, Felga GE, de Arruda Pecora RA, de Almeida MD. Comparison between Milan and UCSF criteria for liver transplantation in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Transl Gastroenterol Hepatol. 2021, 6:11. 10.21037\/tgh.2020.01.06","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2022.118138","article-title":"Surgical management in hepatocellular carcinoma with portal vein tumour thrombosis: is this the end of the road or a chance to expand the criteria for resectability?","volume":"17","author":"Benatatos N","year":"2022","unstructured":"Benatatos N, Papadopoulou I, Assimakopoulos SF, et al.. Surgical management in hepatocellular carcinoma with portal vein tumour thrombosis: is this the end of the road or a chance to expand the criteria for resectability?. Prz Gastroenterol. 2022, 17:257-65. 10.5114\/pg.2022.118138","journal-title":"Prz Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2020.07.003","article-title":"The Impact of Allocation Changes on Patients with Hepatocellular Carcinoma","volume":"24","author":"Yohanathan L","year":"2020","unstructured":"Yohanathan L, Heimbach JK. The Impact of Allocation Changes on Patients with Hepatocellular Carcinoma. Clin Liver Dis. 2020, 24:657-63. 10.1016\/j.cld.2020.07.003","journal-title":"Clin Liver Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/202203-pre-transplant-loco-regional-therapy-for-hepatocellular-carcinoma-and-post-transplant-outcomes-a-national-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T21:45:41Z","timestamp":1724795141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/202203-pre-transplant-loco-regional-therapy-for-hepatocellular-carcinoma-and-post-transplant-outcomes-a-national-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.67960","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,27]]}}}